103 related articles for article (PubMed ID: 7166532)
1. Biosynthetic studies of ebelactone A and B by 13C NMR spectrometry.
Uotani K; Naganawa H; Aoyagi T; Umezawa H
J Antibiot (Tokyo); 1982 Dec; 35(12):1670-4. PubMed ID: 7166532
[TBL] [Abstract][Full Text] [Related]
2. Structural studies on ebelactone A and B, esterase inhibitors produced by actinomycetes.
Uotani K; Naganawa H; Kondo S; Aoyagi T; Umezawa H
J Antibiot (Tokyo); 1982 Nov; 35(11):1495-9. PubMed ID: 7161188
[No Abstract] [Full Text] [Related]
3. Biosynthetic origin of the carbon skeleton and oxygen atoms of the LL-F28249 alpha, a potent antiparasitic macrolide.
Tsou HR; Ahmed ZH; Fiala RR; Bullock MW; Carter GT; Goodman JJ; Borders DB
J Antibiot (Tokyo); 1989 Mar; 42(3):398-406. PubMed ID: 2708133
[TBL] [Abstract][Full Text] [Related]
4. Studies on new antifungal antibiotics, guanidylfungins A and B. II. Structure elucidation and biosynthesis.
Takesako K; Beppu T
J Antibiot (Tokyo); 1984 Oct; 37(10):1170-86. PubMed ID: 6548737
[TBL] [Abstract][Full Text] [Related]
5. Ebelactone, an inhibitor of esterase, produced by actinomycetes.
Umezawa H; Aoyagi T; Uotani K; Hamada M; Takeuchi T; Takahashi S
J Antibiot (Tokyo); 1980 Dec; 33(12):1594-6. PubMed ID: 7251497
[No Abstract] [Full Text] [Related]
6. Studies on cochleamycins, novel antitumor antibiotics. III. Biosyntheses of cochleamycins: incorporation of 13C- and 2H-labeled compounds into cochleamycins.
Shindo K; Sakakibara M; Kawai H; Seto H
J Antibiot (Tokyo); 1996 Mar; 49(3):249-52. PubMed ID: 8626239
[TBL] [Abstract][Full Text] [Related]
7. Letter: 8,8a-Deoxyoleandolide: elaborated by a blocked mutant of the erythromycin-producing organism Streptomyces erythreus.
Martin JR; Egan RS; Goldstein AW; Mueller AL; Hirner EA; Stanaszek RS
J Antibiot (Tokyo); 1974 Jul; 27(7):570-2. PubMed ID: 4457537
[No Abstract] [Full Text] [Related]
8. Metabolic regulation in Streptomyces parvulus during actinomycin D synthesis, studied with 13C- and 15N-labeled precursors by 13C and 15N nuclear magnetic resonance spectroscopy and by gas chromatography-mass spectrometry.
Inbar L; Lapidot A
J Bacteriol; 1988 Sep; 170(9):4055-64. PubMed ID: 3410824
[TBL] [Abstract][Full Text] [Related]
9. Studies on the biosynthesis of 16-membered macrolide antibiotics using carbon-13 nuclear magnetic resonance spectroscopy.
Omura S; Takeshima H; Nakagawa A; Miyazawa J; Piriou F; Lukacs G
Biochemistry; 1977 Jun; 16(13):2860-6. PubMed ID: 18162
[TBL] [Abstract][Full Text] [Related]
10. Urdamycins, new angucycline antibiotics from Streptomyces fradiae. IV. Biosynthetic studies of urdamycins A-D.
Rohr J; Beale JM; Floss HG
J Antibiot (Tokyo); 1989 Jul; 42(7):1151-7. PubMed ID: 2753820
[TBL] [Abstract][Full Text] [Related]
11. Biosynthetic precursors of the lipase inhibitor lipstatin.
Schuhr CA; Eisenreich W; Goese M; Stohler P; Weber W; Kupfer E; Bacher A
J Org Chem; 2002 Apr; 67(7):2257-62. PubMed ID: 11925237
[TBL] [Abstract][Full Text] [Related]
12. Milbemycins, a new family of macrolide antibiotics. Studies on the biosynthesis of milbemycins alpha 2, alpha 4 and D using 13C labeled precursors.
Ono M; Mishima H; Takiguchi Y; Terao M; Kobayashi H; Iwasaki S; Okuda S
J Antibiot (Tokyo); 1983 Aug; 36(8):991-1000. PubMed ID: 6630070
[TBL] [Abstract][Full Text] [Related]
13. Chemistry of bleomycin. XXVI. Biosynthetic study using 13C-enriched precursors.
Nakatani T; Fujii A; Naganawa H; Takita T; Umezawa H
J Antibiot (Tokyo); 1980 Jul; 33(7):717-21. PubMed ID: 6157666
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of ebelactone A: isotopic tracer, advanced precursor and genetic studies reveal a thioesterase-independent cyclization to give a polyketide β-lactone.
Wyatt MA; Ahilan Y; Argyropoulos P; Boddy CN; Magarvey NA; Harrison PH
J Antibiot (Tokyo); 2013 Jul; 66(7):421-30. PubMed ID: 23801186
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of the avermectins by Streptomyces avermitilis. Incorporation of labeled precursors.
Schulman MD; Valentino D; Hensens O
J Antibiot (Tokyo); 1986 Apr; 39(4):541-9. PubMed ID: 3086265
[TBL] [Abstract][Full Text] [Related]
16. Studies on the biosynthesis of bialaphos (SF-1293). 1. Incorporation of 13C- and 2H-labeled precursors into bialaphos.
Seto H; Imai S; Tsuruoka T; Satoh A; Kojima M; Inouye S; Sasaki T; Otake N
J Antibiot (Tokyo); 1982 Dec; 35(12):1719-21. PubMed ID: 7166539
[No Abstract] [Full Text] [Related]
17. Studies on new antifungal antibiotics, guanidylfungins A and B. I. Taxonomy, fermentation, isolation and characterization.
Takesako K; Beppu T
J Antibiot (Tokyo); 1984 Oct; 37(10):1161-9. PubMed ID: 6548736
[TBL] [Abstract][Full Text] [Related]
18. Studies on the biosynthesis of the erythromycins. II. Isolation and structure of a biosynthetic intermediate, 6-deoxyerythronolide B.
Martin JR; Rosenbrook W
Biochemistry; 1967 Feb; 6(2):435-40. PubMed ID: 6047629
[No Abstract] [Full Text] [Related]
19. Valilactone, an inhibitor of esterase, produced by actinomycetes.
Kitahara M; Asano M; Naganawa H; Maeda K; Hamada M; Aoyagi T; Umezawa H; Iitaka Y; Nakamura H
J Antibiot (Tokyo); 1987 Nov; 40(11):1647-50. PubMed ID: 3693135
[No Abstract] [Full Text] [Related]
20. Kazusamycin B, a novel antitumor antibiotic.
Funaishi K; Kawamura K; Sugiura Y; Nakahori N; Yoshida E; Okanishi M; Umezawa I; Funayama S; Komiyama K
J Antibiot (Tokyo); 1987 Jun; 40(6):778-85. PubMed ID: 3610834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
